Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD) Aged Between 45-75 Years

NCT01516437 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01516437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01516437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable Chronic Obstructive Pulmonary Disease (COPD) Aged Between 45-75 Years
Lead sponsor
GlaxoSmithKline
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2012
Completion date
December 20, 2012
Enrollment
73 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory disorders